The latest FRAME Annual Lecture was a huge success and sparked an in-depth debate on the future of drug development and testing.
Speaker Dr Malcolm Skingle, Director of Academic Liaison at Glaxo Smith Kline, discussed using […]
FRAME has appointed a new Director to oversee its research programme at the Nottingham office. Dr Gerry Kenna is a drug safety scientist with extensive industrial safety assessment experience, including 11 years in the pharmaceutical […]
The RSPCA has drawn up a plan that aims to end severe suffering for animals used in research and testing. The road-map has been released in response to changes in EU and UK legislation and […]
FRAME is calling for more collaboration between alternatives organisations, government and the pharmaceutical industry following publication of a new investigation of preclinical drugs trials using laboratory animals.
Scientific papers covering more than 2,300 substances tested on rats, […]
A further increase in the use of genetically altered (GA) animals in laboratories flouts EU regulations and is in direct opposition to the UK Government’s pledge to reduce the numbers involved. If the Government is going […]
As part of an ongoing programme of modernisation FRAME has overhauled its website and updated the content. The process began two years ago with the launch of PiLAS (Perspectives in Laboratory Animal Science), which was […]
Call for research to move to humans as soon as possible
FRAME welcomes the fact that researchers who carried out an experiment offering hope to spine-damaged patients have, where possible, minimised the distress for the animals […]